Publications by authors named "Marco Merlano"

Claim this Profile
P
Predicting the response to immunotherapy from gene expression data in HER2-negative breast cancer.
Caterina A M La Porta, Ornella Garrone, Marco Merlano, Stefano Zapperi

Commun Med (Lond)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review.
Ornella Garrone, Fiorella Ruatta, Carmen Giusy Rea, Nerina Denaro, Michele Ghidini, Marco C Merlano

Cancers (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database.
Sujith Baliga, Ahmad K Abou-Foul, Pablo Parente, Petr Szturz, Juliette Thariat, Marco Carlo Merlano

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
Mara Serena Serafini, Stefano Cavalieri, Lisa Licitra, Federico Pistore, Deborah Lenoci, Marco Merlano

J Immunother Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.
Marco Carlo Merlano, Matteo Paccagnella, Nerina Denaro, Andrea Abbona, Danilo Galizia

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
Elisabetta Roberti, Marco Merlano, Marco Ravanelli, Andrea Alberti, Andrea Esposito

Oral Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oligometastatic setting in HNSCC: A critical review by the Rete Oncologica Piemonte e Valle d'Aosta multidisciplinary team.
Nerina Denaro, Giovanni Succo, Oliviero Ostellino, Mario Airoldi, Marco Carlo Merlano

Crit Rev Oncol Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking.
Marco Carlo Merlano, Nerina Denaro, Danilo Galizia, Andrea Abbona, Matteo Paccagnella

Oncology· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib.
Andrea Abbona, Vincenzo Ricci, Matteo Paccagnella, Cristina Granetto, Fiorella Ruatta, Marco Carlo Merlano

Vaccines (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience.
Nerina Denaro, Ornella Garrone, Michele Ghidini, Gianluca Tomasello, Jens Claus Hahne, Marco Carlo Merlano

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A narrative review of the principal glucocorticoids employed in cancer.
Nerina Denaro, Ornella Garrone, Annamaria Morelli, Benedetta Pellegrino, Marco Carlo Merlano

Semin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Cytokinome in the HNSCC Tumor Microenvironment: A Narrative Review and Our Experience.
Nerina Denaro, Cinzia Solinas, Ornella Garrone, Carolina Cauchi, Fiorella Ruatta, Marco Carlo Merlano

Diagnostics (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Risk Factors Affect Head and Neck Squamous Cell Carcinoma (HNSCC) Tumor Immune Microenvironment (TIME): Their Influence on Immune Escape Mechanisms and Immunotherapy Strategy.
Danilo Galizia, Silvia Minei, Elena Maldi, Giovanna Chilà, Alessio Polidori, Marco Carlo Merlano

Biomedicines· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review.
Marco Carlo Merlano, Nerina Denaro, Danilo Galizia, Fiorella Ruatta, Marcella Occelli

Biomedicines· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Eribulin on Angiogenesis and the Expression of Endothelial Adhesion Molecules.
Andrea Abbona, Matteo Paccagnella, Simonetta Astigiano, Stefania Martini, Nerina Denaro, Marco Merlano

Anticancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In reply to immune desert in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment.
Nerina Denaro, Marco Merlano, Ornella Garrone

Oral Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression.
Matteo Paccagnella, Andrea Abbona, Andrea Michelotti, Elena Geuna, Fiorella Ruatta, Marco Merlano

Vaccines (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response to immunotherapy in sinonasal undifferentiated carcinoma.
Nerina Denaro, Marco Merlano, Gianmauro Numico, Ornella Garrone, Paolo Bossi

Tumori· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 and Anti-PD-L1 in Head and Neck Cancer: A Network Meta-Analysis.
Andrea Botticelli, Alessio Cirillo, Lidia Strigari, Filippo Valentini, Bruna Cerbelli, Marco Carlo Merlano

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?
Paolo Bossi, Cristina Gurizzan, Luigi Lorini, Pierluigi di Mauro, Chiara Sardini, Marco Merlano

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review.
Nerina Denaro, Ornella Garrone, Marcella Occelli, Elena Fea, Cristina Granetto, Marco Carlo Merlano

Eur J Case Rep Intern Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis.
Nerina Denaro, Marco Carlo Merlano, Cristiana Lo Nigro

Cancer Manag Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study.
Valentina D A Corino, Marco Bologna, Giuseppina Calareso, Lisa Licitra, Mariagrazia Ghi, Marco Merlano

Diagnostics (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy.
Marco Carlo Merlano, Andrea Abbona, Matteo Paccagnella, Antonella Falletta, Cristina Granetto

Vaccines (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC).
Nerina Denaro, Anna Maria Merlotti, Marco Carlo Merlano, Elvio Russi

Oral Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis